FAR: Filtrate, Alternate, Return.
Since the early 1900s, the drug industry has been revolutionized. Biologics began to take their stance, leaving everyday chemicals behind. It was groundbreaking when vaccines and antibiotics entered our lives. Then came CRISPR in the 2010s —and once again, bacterial immunity started saving lives.
But releasing the ultimate genetic modifier into the body was not unlike letting a pandemic loose in a city human-sized. Even with precise targeting, laboratory work could still take days or weeks for patients who could not afford patience —only to face chemotherapy afterwards.
FAR is more than a biomedical start-up. It is our way of shouldering the responsibility we were destined to carry —for children, adults, anyone anywhere in the world struggling with a genetic setback, when they could instead be sharing in life’s simplest rights: to breathe, to walk, to smile.
With our motive stated, we present our next-generation, cell-specific apheresis device —an initiation into a new age of automated gene therapies. By directly connecting patients with biologic therapeutics, FAR builds an essential bridge between the people we love… and the chance to stay in this world a bit longer, to love more.
If you share a similar mission at heart, lets stay in touch. We know it is limited one person or a team can achieve, but we also know the world is not going to decide becoming a better place for its dear residents inside.
FAR, a technology for those who imagine further into the depths of atoms, cells and skies. Cure is not far away, as long as you and I are willing to take things... a little further.
Get better, with FAR Better.
Collaboration
Partnership